A key patent protecting Neotherix' bioresorbable tissue regeneration scaffold technology has now been granted in the United States. US patent 8,338,402 was issued by the United States Patent and Trademark Office (USPTO) on 25 December 2012 and is licensed to Neotherix by Smith & Nephew PLC for a wide range of soft tissue repair, dental and surgical applications.
The patent describes scaffolds (including those made by electrospinning) that can be used as medical devices for guided tissue regeneration and repair, in particular scaffolds comprising fibres having a mean fibre diameter of between 1.9 to 2.6 µm wherein the fibres comprise over 95% glycolide. Another patent in the same family was previously granted in South Africa (ZA 2008/09489), with further applications being pursued in other regions including Europe, China and Australia.
The patent is available to view on the USPTO web site .